AVXL
Price:
$4.45
Market Cap:
$397.60M
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the trea...[Read more]
Industry
Biotechnology
IPO Date
2006-08-02
Stock Exchange
NASDAQ
Ticker
AVXL
According to Anavex Life Sciences Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 296.44M. This represents a change of -51.31% compared to the average of 608.80M of the last 4 quarters.
The mean historical Enterprise Value of Anavex Life Sciences Corp. over the last ten years is 383.56M. The current 296.44M Enterprise Value has changed 7.63% with respect to the historical average. Over the past ten years (40 quarters), AVXL's Enterprise Value was at its highest in in the June 2021 quarter at 1.46B. The Enterprise Value was at its lowest in in the December 2018 quarter at 51.55M.
Average
383.56M
Median
288.72M
Minimum
92.28M
Maximum
1.10B
Discovering the peaks and valleys of Anavex Life Sciences Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 367.38%
Maximum Annual Enterprise Value = 1.10B
Minimum Annual Increase = -42.35%
Minimum Annual Enterprise Value = 92.28M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 656.50M | 92.01% |
| 2024 | 341.91M | -7.99% |
| 2023 | 371.59M | -42.35% |
| 2022 | 644.55M | -41.45% |
| 2021 | 1.10B | 367.38% |
| 2020 | 235.54M | 77.96% |
| 2019 | 132.36M | 43.43% |
| 2018 | 92.28M | -34.85% |
| 2017 | 141.64M | 19.61% |
| 2016 | 118.42M | 32.14% |
The current Enterprise Value of Anavex Life Sciences Corp. (AVXL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
456.67M
5-year avg
623.08M
10-year avg
383.56M
Anavex Life Sciences Corp.’s Enterprise Value is less than Erasca, Inc. (888.32M), less than MeiraGTx Holdings plc (679.86M), less than MoonLake Immunotherapeutics (724.26M), less than Arvinas, Inc. (819.49M), less than MBX Biosciences, Inc. Common Stock (803.43M), less than Astria Therapeutics, Inc. (677.40M), less than CytomX Therapeutics, Inc. (662.44M), less than Valneva SE (679.99M), less than REGENXBIO Inc. (674.74M), less than Absci Corporation (530.11M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 888.32M | $905.04M | |
| 679.86M | $692.22M | |
| 724.26M | $955.18M | |
| 819.49M | $911.69M | |
| 803.43M | $1.03B | |
| 677.40M | $748.95M | |
| 662.44M | $691.03M | |
| 679.99M | $742.49M | |
| 674.74M | $657.04M | |
| 530.11M | $560.88M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anavex Life Sciences Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anavex Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Anavex Life Sciences Corp.'s Enterprise Value?
What is the highest Enterprise Value for Anavex Life Sciences Corp. (AVXL)?
What is the 3-year average Enterprise Value for Anavex Life Sciences Corp. (AVXL)?
What is the 5-year average Enterprise Value for Anavex Life Sciences Corp. (AVXL)?
How does the current Enterprise Value for Anavex Life Sciences Corp. (AVXL) compare to its historical average?